Exousia Bio, Inc. (LMMY)
Exousia Bio, Inc. is a biotechnology company that designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026.
Sector: Services-Educational Services
Industry: Education & Training Services
L A M Y
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
based on 52.50M shares outstanding
USLAMY conceptualizes, builds, and runs an online marketplace dedicated to e-learning and gaming.
Its flagship product, "TwoPlus1," is an educational video game specifically crafted to impart vital financial literacy and effective resource management skills to a youth audience. Headquartered in New York, New York, the company was established in 2022.
Leadership
Matthew Dwyer
President, CEO, CFO, Treasurer, Secretary & Director
Employees
2
Country
US
Sector
Consumer Defensive
Website
lamy.com
based on 52.50M shares outstanding
US30d Avg
14.43K
60d Avg
28.47K
90d Avg
86.84K